ABIVAX: Statement of share capital and voting rights as of September 30, 2026

On October 23, 2026, ABIVAX, listed on Euronext Paris (ABVX), published the number of shares comprising its share capital, as well as the total number of voting rights as of September 30, 2026. The company declared a share capital of 875,481 euros, divided into 87,541,485 shares.

Regarding voting rights, the press release specifies that the number of theoretical and exercisable voting rights is 88,796,742. According to Article 223-11 of the AMF General Regulation, this total includes shares without voting rights. This figure is essential for calculating the regulatory thresholds for voting rights. However, the number of exercisable voting rights is adjusted to exclude these shares without voting rights.